Peptide directorySkin, immune & repair

HNP-1

The most abundant defensin, packed into the neutrophil’s granules.

Where it comes from

Made in
Neutrophils, which store it in their azurophilic granules; some in natural killer and T cells and in monocytes
Sent out by
When the neutrophil swallows a microbe or dies at a site of infection
Acts on
  • Bacteria, fungi and enveloped viruses
  • Immune cells (chemotaxis)
  • Host cells at high concentration

What it does

  • Kills microbes inside the phagosome
  • Blocks bacterial toxins (anthrax lethal factor, diphtheria toxin) by binding them
  • Attracts T cells and immature dendritic cells
  • Toxic to the body’s own cells at high levels, as in inflamed lungs

In medicine

  • Measured in research as a marker of neutrophil activation; high in the sputum of cystic fibrosis and in sepsis
  • No medicine. Its gene sits in a tandem array of four to eleven copies per person, and the proportions of HNP-1 and HNP-3 follow the copies 3

Beyond the body’s own use

  • Defensins inspired many antimicrobial peptide drugs; none built on HNP-1 has reached approval
  • It binds and neutralises anthrax lethal toxin, and protected mice against a lethal dose of it, which is studied as a way to blunt toxin-driven disease 2
  • Copy number of the gene array is studied as a risk factor in infection; what it does to the total amount of defensin a person makes is not settled 3

Sources

  1. Ganz et al., Defensins: natural peptide antibiotics of human neutrophils, Journal of Clinical Investigation 1985
  2. Kim et al., Human alpha-defensins neutralize anthrax lethal toxin, Proceedings of the National Academy of Sciences 2005
  3. Aldred et al., Copy number polymorphism of the alpha-defensin genes DEFA1 and DEFA3, Human Molecular Genetics 2005

This card describes what a medicine is for and what the evidence says; it recommends nothing. Talk to your clinician about anything you read here.